The most important moment in Weekly Care’s cancellation policy is not delivery. It is the transmission of a prescription to the pharmacy. Before that point, the policy allows cancellation for a refund after a consultation; afterward, ordinary cancellation and refund are no longer available. That boundary deserves attention before enrolling, especially because the platform also offers automatically renewing subscriptions and discusses six-month plans without publishing their complete financial structure in the consulted pages.
Weekly Care presents an online route to compounded semaglutide and tirzepatide through independent clinicians and partner pharmacies. Its advertised starting prices are clear, but the commitments needed to obtain them are not. This review examines public documentation consulted October 19, 2026, with particular attention to the agreement a patient would be entering. It does not verify licenses, test customer service or establish treatment results. The central question is whether the documented responsibilities and exit rules are sufficiently clear before payment.
At a glance
- Advertised starting prices
- Compounded Semaglutide+ starts at $89/month and Compounded Tirzepatide+ at $99/month, with the same advertised price at every dose. The consulted pricing block does not establish the commitment or supply quantity required.Sources: [5]
- Platform, not treating practice
- Weekly Care’s terms say it is not a healthcare provider. Independent providers evaluate patients, and partner pharmacies fulfill prescriptions.
- Automatic billing
- Certain services require automatically renewing subscriptions, with billing intervals disclosed during checkout. The terms allow pause or cancellation requests.Sources: [3]
- Refund boundary
- After a consultation, cancellation for a refund is available before pharmacy submission. Once the prescription is transmitted, the policy says cancellation and refund are no longer possible.Sources: [2]
- Operational shipping window
- Medication is generally dispatched within 2–4 business days following provider approval and pharmacy preparation, with no weekend or federal-holiday shipments.Sources: [2]
Start with the exit rules, not the monthly headline
Weekly Care separates ending a plan from canceling a medication order. To end a plan, its policy instructs patients to email help@weekly.care. Once cancellation is confirmed, the plan remains active through the current billing cycle and further renewals stop. Unused time within that cycle does not qualify for a partial or prorated refund. Sending a request and receiving confirmation are therefore distinct events under the wording; retaining both messages would help document what was requested and acknowledged.
The medication-order rule is more restrictive. A patient who has completed a live or message-based consultation may cancel for a refund if the order has not yet been submitted to the pharmacy. Once the prescription has been transmitted, the policy closes that ordinary cancellation-and-refund route. It does not make receipt of the package the deciding event. Someone considering enrollment should ask how to learn the order’s current status and whether submission follows immediately after clinical approval.
The terms also say a subscription may be paused or canceled at any time, but that should not be read as a promise to reverse an existing order or return already collected money. These provisions address different stages of the relationship. Our guide to cancellation notice, renewal dates and order status explains why those distinctions matter. Weekly Care’s consulted policy does not establish a specific advance-notice deadline, so patients should obtain the applicable renewal date and processing requirements in writing.
| Event | Documented treatment | Important boundary |
|---|---|---|
| Plan cancellation confirmed | Active through current cycle; no further renewals | No prorated refund for unused cycle time |
| Consultation completed, before pharmacy submission | Cancellation for a refund is allowed | Confirm whether the order has already been transmitted |
| Prescription transmitted to pharmacy | Ordinary cancellation and refund are unavailable | The cutoff precedes delivery |
| Provider finds patient medically ineligible | Order canceled with a full refund | This follows the provider’s review |
| Six-month plan with at least three months remaining | Unused-portion refund may be requested | Eligibility is discretionary, not automatic |
What the advertised price does—and does not—buy
The homepage advertises Compounded Semaglutide+ starting at $89 per month and Compounded Tirzepatide+ starting at $99 per month. Both listings say the price is the same at every dose. The product pages describe subcutaneous injections, rather than oral products. However, the consulted documentation does not identify the added components represented by the plus sign, the exact formulation assigned to an individual, or the presentation and quantity supplied at either starting price.
Weekly Care says prescribed medication, provider visits, supplies, shipping and ongoing care are included in its treatment offering, with no separate monthly membership or provider fees. Those are meaningful advertised inclusions, but they do not resolve the enrollment total. The consulted pages do not explain what commitment, advance payment or other condition qualifies a patient for the lowest price. Nor do they establish whether the first charge differs from subsequent charges or what laboratory services, if any, are required and separately priced.
The terms put regular subscription billing intervals at checkout rather than fixing one universal schedule in the public language reviewed here. The cancellation policy acknowledges six-month plans, yet the total price, collection schedule and dispensing schedule for those plans remain undocumented in the consulted material. A monthly headline therefore cannot establish a month-to-month commitment. Before authorizing payment, request the complete checkout terms alongside a written GLP-1 quote, including the initial charge, renewal amount, billing interval and supplied quantity.
Who owes the patient which service
The privacy policy identifies Weekly Care LLC as the website’s owner and operator. Its terms expressly say Weekly Care is not a healthcare provider and does not itself supply healthcare or healthcare advice. Instead, it connects registered users with providers, pharmacies and associated services. That distinction matters when an issue arises: a billing dispute with the platform, a treatment question for a clinician and a dispensing concern for a pharmacy are not interchangeable responsibilities, even if the customer encounters them through one website.
The homepage identifies David Wasef, MD, as Wasef Health’s founder and medical director and says Weekly Care partners with Wasef Health for access to licensed medical providers. Those providers review health information, determine whether treatment is appropriate and offer ongoing medical care. Enrollment begins with a medical intake, not a guaranteed prescription. If an independent provider considers a person an appropriate candidate, that provider may prescribe, after which a partner pharmacy can fulfill and ship the medication.
The terms require separate electronic informed consent for telehealth and acknowledge that remote care does not replace an in-person evaluation in every circumstance. They also assign medical-record retention to the treating provider, not Weekly Care; copies must be requested directly from that provider. A practical enrollment checklist should therefore capture the treating practice’s name, contact route and records process. Our explanation of platform, clinician and pharmacy responsibilities provides a framework for organizing those details without treating the platform as the medical practice.
Refund exceptions are narrower than a satisfaction guarantee
Weekly Care provides a clear refund route when a licensed provider determines after review that a patient is not medically eligible: the order is canceled and a full refund is due. Other circumstances are less automatic. For a six-month plan with three or more months remaining, cancellation does not itself create refund eligibility. A patient may request return of the unused portion, but the company reserves sole discretion over qualification. The policy does not establish the complete financial terms of that six-month arrangement.
Service dissatisfaction also has limits. Delays or communication problems do not automatically qualify for refunds, although Weekly Care may review them individually. Confirmed duplicate charges and billing errors do qualify for refunds. These are different promises: a billing correction is not the same as a general guarantee that an inconvenient experience can be unwound. The distinction is especially relevant if a patient expects quick fulfillment and wants to cancel after the order has already crossed the pharmacy-submission boundary.
Refund timing has two stages. Requests are reviewed within 2–4 business days, with notification of the outcome. Approved refunds are returned to the original payment method within 5–10 business days, but the policy allows additional time for a bank or card issuer to post the credit. That is not a guarantee of available funds within ten business days of the initial complaint. The consulted cancellation policy displays an effective and last-updated date of September 9, 2026; its historical application to a particular transaction was not established.
Delivery estimates do not promise an enrollment-to-door deadline
The homepage advertises provider review in one day and delivery in one to two days, contingent on a prescription being issued. It also promotes two-day shipping. Those statements are accompanied by a qualification: timelines are estimates and can vary with provider review, prescription approval, pharmacy processing, medication availability and shipping conditions. They should not be combined into a guaranteed deadline measured from questionnaire completion. Clinical review, pharmacy preparation and carrier transit remain separate steps.
The operating policy supplies the more useful planning detail. Medications are generally shipped within 2–4 business days following provider approval and pharmacy preparation. Fulfillment runs Monday through Friday, with no shipments on weekends or U.S. federal holidays. Expedited transport may use UPS 2nd Day Air or a comparable service. Dispatch is not arrival, and the policy’s preparation and shipping window should not be mistaken for a promise that medication will reach the patient within that same period.
Tracking details are emailed when an order ships, and carrier tracking can take up to 24 hours to activate. This gives patients a concrete contact trail but does not eliminate the gap between approval and dispatch. Before paying, it is reasonable to ask when the pharmacy normally receives the prescription, what event triggers shipment and how a delay is escalated. That matters contractually because delays alone do not automatically generate refund eligibility, while pharmacy transmission already restricts ordinary cancellation.
Inspect deliveries promptly, without confusing refund policy with safety
Weekly Care requires damage reports within 24 hours of delivery, sent to help@weekly.care with a clear photograph. Packaging materials must be retained. After verification, the company says it will arrange a replacement or issue a refund; requests outside the window may not be honored. A shipment marked delivered but not received also carries a 24-hour reporting requirement, with documentation such as a missing-package claim. If theft is suspected, a police report may be required before replacement is considered.
Its temperature-related policy is narrower than some readers might expect: melted ice packs, packaging differences or outside-temperature changes alone do not qualify for replacement or refund unless Weekly Care or the pharmacy determines medication integrity was compromised. That is a commercial remedy rule, not a clinical instruction to use a questionable delivery. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy to resolve the concern.
Keeping the two questions separate is essential: whether a product should be used and whether the seller will reimburse it are not the same determination. Promptly preserve photos, packaging and written communications while contacting the appropriate clinical or pharmacy team. Weekly Care’s documentation does not establish a temperature-measurement protocol for patients or an automatic replacement entitlement in every refrigeration dispute. Our guide to refund guarantees and their exclusions explains how to read a remedy policy without treating it as a safety assessment.
Pharmacy choice and national availability have qualifications
Weekly Care says its services are available in all 50 states and Washington, D.C., but not outside the United States. The terms restrict access to people at least 18 years old who are located in the United States, with possible additional age restrictions for certain products. The homepage says affiliated providers are licensed where patients are located and pharmacy partners are licensed to serve those states. These are provider statements, not independently verified licensing findings; medications, formulations and fulfillment options may vary by state.
The company names Hallandale Pharmacy and VialsRx among its 503A compounding-pharmacy partners. That list does not establish which pharmacy would serve a particular patient or identify the patient’s exact formulation. The terms also permit prescriptions to be filled and transferred among network pharmacies. For certain prescriptions, patients may choose an outside pharmacy, but then they must obtain the medication themselves and pay that pharmacy directly. The advertised bundled arrangement should not be assumed to cover an outside pharmacy’s medication charge.
Both advertised products are compounded injections. Weekly Care acknowledges that compounded medications are not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but neither a contract nor an advertised pharmacy partnership establishes treatment outcomes. Clarifying the prescribed formulation and dispensing pharmacy remains a task for the actual care relationship.
Ongoing access, payment and privacy need separate confirmation
Weekly Care operates on a self-pay basis and does not bill insurance. It says HSA or FSA reimbursement may be available depending on the individual plan; that is not a reimbursement guarantee. Alongside the financial questions, patients should clarify what continued care entails. The homepage promises ongoing support from the partner medical team and administrative support seven days a week for shipments, orders and related matters, but it does not establish clinician hours, response deadlines or a fixed consultation and monitoring schedule.
The privacy policy says communications with healthcare providers occur exclusively through the HIPAA-governed patient portal. Administrative availability therefore should not be mistaken for continuous clinical access. The consulted pages also do not confirm Spanish-language clinical care or interpretation. Before enrollment, ask where urgent treatment concerns should go, how routine questions reach the prescriber and whether any required testing adds charges. These are unresolved operational details, not evidence that follow-up or language assistance is unavailable.
Privacy documentation adds another distinction. The general policy describes sharing certain identifiers and online activity with advertising and analytics partners while excluding protected health information governed by its HIPAA notice from advertising or marketing disclosure. The California notice says the company does not sell personal information or share it for cross-context behavioral advertising. The consulted wording warrants clarification about the information and activities covered, but it does not establish that the statements are legally incompatible or that every website interaction receives the same protections as clinical portal communication.
Questions & answers
Can I enroll for just one month at $89 or $99?
The consulted pages do not establish that. Those are starting monthly prices for Compounded Semaglutide+ and Compounded Tirzepatide+, respectively, not confirmed one-month purchase offers. The policy mentions six-month plans without documenting their total price or payment schedule. Ask for the commitment, amount due immediately, renewal amount and quantity supplied before treating either advertised figure as a complete quote.
How do I stop Weekly Care renewals?
The cancellation policy directs patients to email help@weekly.care. Once confirmed, the plan continues through the current billing cycle and no further renewals are charged. Unused cycle time is not prorated. Keep the request and confirmation, and ask which scheduled charge will be stopped. Ending future renewals does not itself cancel or refund a prescription already transmitted to the pharmacy.
What happens if the clinician does not prescribe?
Weekly Care does not guarantee a prescription. An independent provider reviews the medical intake and decides whether treatment is appropriate. Its refund policy says that if a licensed provider determines after review that the patient is medically ineligible, the order is canceled with a full refund. Refund review, issuance and bank posting are separate stages, so an approved refund need not appear immediately.
Can I use my own pharmacy?
The terms allow an outside pharmacy for certain prescriptions. Weekly Care says the prescription will be sent to the selected pharmacy, but the patient must arrange pickup or other receipt and pay that pharmacy directly. This is not a promise that every formulation is available everywhere or that the outside medication cost is included in the advertised plan. Confirm both availability and financial treatment first.
Does seven-day support mean a clinician is always available?
No such schedule is established in the consulted documentation. Weekly Care advertises seven-day administrative help for orders, shipping and related issues, alongside ongoing care from its partner medical team. The privacy policy directs healthcare-provider communications exclusively through the patient portal. It does not specify a medical response deadline. Ask for the clinical contact pathway and expected turnaround separately from customer-service availability.
What if my medication arrives warm or the package is damaged?
FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or pharmacy. Separately, Weekly Care requires damage reports within 24 hours, with photographs and retained packaging. Melted ice packs alone do not automatically trigger its refund or replacement policy. Contact the company promptly while also seeking pharmacy or clinical guidance about the medication itself.
Our assessment
Weekly Care documents several useful boundaries: included services, a medical-ineligibility refund, an email cancellation route and concrete delivery-incident requirements. Its principal weaknesses for a prospective customer are incomplete starting-price conditions, undocumented six-month financial details and an early pharmacy-submission cutoff for ordinary refunds. The service may offer a coordinated online access route, but its platform, clinicians and pharmacies retain different responsibilities. Before enrolling, obtain the complete payment schedule, renewal date, pharmacy-submission process and clinical follow-up arrangements in writing. Judge those terms separately from medical suitability and from any expectation of treatment results.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Weekly Care — shipping and refund ↗
- Weekly Care — terms and conditions ↗
- Weekly Care — privacy policy ↗
- Weekly Care — official website ↗
- Weekly Care — california privacy notice ↗
- Weekly Care — safety compounded semaglutide ↗
- Weekly Care — safety compounded tirzepatide ↗